People with Parkinson’s disease are receiving a new treatment in a clinical trial started after University of Wisconsin-Madison scientists demonstrated the safety and feasibility of the therapeutic delivery method in a study of non-human primates.
People with Parkinson’s disease are receiving a new treatment in a clinical trial started after University of Wisconsin-Madison scientists demonstrated the safety and feasibility of the therapeutic delivery method in a study of non-human primates.